Qualcomm Incorporated

Global Alliance for Tb Drug Development

Jingbin Wang

Yang Liu

Hao Zhang

Kai Liu

Yu Chen

Zhenkun Ma

Gang Zhang

Chun Li

Christopher Blair Cooper

Dongfeng Zhang

Haihong Huang

Dali Yin

Xiaoming Bao

Binna Liu

A device including one or more processors configured to, based on at least one of an external criterion or a signal-based criterion, output a first gain adjusted signal from a first gain adjuster or a second gain adjusted signal from a second gain adjuster as an input to an audio processing operation. The first gain adjusted signal corresponds to a first gain applied to an audio signal from a microphone and the second gain adjusted signal corresponding to a second gain applied to an audio signal from a microphone. The signal-based criterion is based on whether a first signal metric associated with the first gain adjusted signal or a second signal metric associated with the second gain adjusted signal is closer to a target metric.

Audio gain selection

The present invention relates to riminophenazines having heteroaromatic substitutions, including those with 2-heteroaryl-amino substituents, to their preparation, and to their use as drugs for treatingand other microbial infections, either alone or in combination with other anti-infective treatments. A general representation of the 2-(heteroaryl)amino-riminophenazines is shown below. 

Riminophenazines with 2-(heteroaryl)amino substituents and their anti-microbial activity

Growing community of inventors

Beijing, China

Jingbin Wang